SCHEMBL9267992

SCHEMBL9267992

NC(=O)N(c1ccccc1)c1ccccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.48
ALDH1A1 P00352 5/20 0.45
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 3/20 0.41
KDM4E B2RXH2 2/20 0.41
TSHR P16473 2/20 0.41
HSD17B10 Q99714 2/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
ATM Q13315 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.38
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6037482 0.86 TRPM8 (0.40) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL5271426 0.84 AKR1B1 (0.46) POLBHTTHPGDMAPTKDM4E
SCHEMBL27500838 0.82 TRPM8 (0.43) POLBKMT2ANPC1RAB9AHPGD
SCHEMBL4357535 0.82 HTR3E (0.43) ALDH1A1HTTRAB9AMAPTTSHR
SCHEMBL7549706 0.81 CYP3A4 (0.43) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL27693005 0.81 ATM (0.42) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL75883 0.81 NPSR1 (0.64) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL75885 0.81 NPSR1 (0.64) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL28148401 0.81 NPSR1 (0.64) NPSR1ALDH1A1POLBKMT2ANPC1
SCHEMBL17103009 0.81 NPSR1 (0.48) NPSR1ALDH1A1POLBKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0653677-A1 Colour photographic material containing a coupler Agfa-Gevaert AG (DE) 1995-05-17 EP claimed
EP-0254151-B1 COLOUR PHOTOGRAPHIC MATERIAL CONTAINING COUPLERS Agfa-Gevaert AG (DE) 1990-12-05 EP claimed
EP-3636446-B1 RECORDING MATERIAL, RECORDING SHEET AND USE OF A COMPOUND AS COLOUR-DEVELOPING AGENT NIPPON SODA CO (JP) 2025-04-16 EP disclosed
US-11529819-B2 Recording material and compound NIPPON SODA CO., LTD. (JP) 2022-12-20 US disclosed
CN-1539816-A IL-8 receptor antagonists ʷ��˿�������ȳ�ķ���޹�˾ 2004-10-27 CN disclosed
CN-1355697-A IL-8 receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-06-26 CN disclosed
CN-1215990-A IL-8 receptor antagonists SMITHKLINE BEECHAM CORP (US) 1999-05-05 CN disclosed
EP-0422462-B1 Colour photographic recording material with couplers which release heat-stable dyes AGFA GEVAERT AG (DE) 1995-09-06 EP disclosed
EP-0653677-A1 Colour photographic material containing a coupler Agfa-Gevaert AG (DE) 1995-05-17 EP disclosed
US-5200305-A Production of color negatives for multicopy operation AGFA GEVAERT AKTIENGESELLSCHAFT (DE) 1993-04-06 US disclosed
EP-0422462-A2 Colour photographic recording material with couplers which release heat-stable dyes Agfa-Gevaert AG (DE) 1991-04-17 EP disclosed
EP-0254151-B1 COLOUR PHOTOGRAPHIC MATERIAL CONTAINING COUPLERS Agfa-Gevaert AG (DE) 1990-12-05 EP disclosed
EP-0254151-A2 Colour photographic material containing couplers Agfa-Gevaert AG (DE) 1988-01-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11529819-B2 Recording material and compound H1-0, DOT1L, H1-4 NPSR1 1819/4885ALDH1A1 1091/4885POLB 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.